UTILITY OF HIGH-DENSITY LIPOPROTEIN (HDL) CHOLESTEROL, PARTICLE CONCENTRATION, AND SIZE IN PREDICTING FUTURE MAJOR ADVERSE CARDIOVASCULAR EVENTS AMONG PATIENTS UNDERGOING ANGIOGRAPHY: THE INTERMOUNTAIN HEART COLLABORATIVE STUDY

被引：1
|
作者：
May, Heidi Thomas
Anderson, Jeffrey
Winegar, Deborah
Rollo, Jeffrey
Connelly, Margery
Otvos, James
Muhlestein, J.
机构：
[1] Intermt Med Ctr, Murray, UT USA
[2] Univ Utah, Salt Lake City, UT USA
来源：
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY | 2014年 / 63卷 / 12期
关键词：
D O I：
10.1016/S0735-1097(14)61318-8
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1112-143
引用
收藏
页码：A1318 / A1318
页数：1
相关论文
共 50 条
  • [21] Association between high-density lipoprotein cholesterol levels and major adverse cardiovascular events in patients who underwent coronary computed tomography angiography: FU-CCTA registry
    Yuto Kawahira
    Yuhei Shiga
    Hiroko Inoue
    Yasunori Suematsu
    Kohei Tashiro
    Yuta Kato
    Kanta Fujimi
    Yosuke Takamiya
    Takashi Kuwano
    Makoto Sugihara
    Shin-ichiro Miura
    Heart and Vessels, 2021, 36 : 1457 - 1465
  • [22] HIGH-DENSITY LIPOPROTEIN (HDL) SUBFRACTIONS IN CARDIOVASCULAR PATIENTS WITH LOW-LEVELS OF HDL-CHOLESTEROL - INFLUENCE OF HYPERTRIGLYCERIDEMIA ON SUBFRACTION CONCENTRATION AND COMPOSITION
    HONG, ML
    JAMES, RW
    GRAB, B
    POMETTA, D
    ATHEROSCLEROSIS, 1988, 69 (2-3) : 241 - 248
  • [23] Impact of Paradoxical Decrease in High-density Lipoprotein Cholesterol Levels After Statin Therapy on Major Adverse Cardiovascular Events in Patients with Stable Angina Pectoris
    Hirayama, Kenshi
    Ota, Tomoyuki
    Harada, Kazuhiro
    Shibata, Yohei
    Tatami, Yosuke
    Harata, Shingo
    Kawashima, Kazuhiro
    Kunimura, Ayako
    Shimbo, Yusaku
    Takayama, Yohei
    Kawamiya, Toshiki
    Yamamoto, Dai
    Osugi, Naohiro
    Suzuki, Susumu
    Ishii, Hideki
    Murohara, Toyoaki
    CLINICAL THERAPEUTICS, 2017, 39 (02) : 279 - 287
  • [24] Uric acid to high-density lipoprotein cholesterol ratio predicts adverse cardiovascular events in patients with coronary chronic total occlusion
    Yang, Yu
    Zhang, Jian
    Jia, Lin
    Su, Jiannan
    Ma, Mengqing
    Lin, Xianhe
    NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES, 2023, 33 (12) : 2471 - 2478
  • [25] GLYCA AND GLYCB, NOVEL NMR BIOMARKERS OF INFLAMMATION, STRONGLY PREDICT FUTURE CARDIOVASCULAR EVENTS, BUT NOT THE PRESENCE OF CORONARY ARTERY DISEASE (CAD), AMONG PATIENTS UNDERGOING CORONARY ANGIOGRAPHY: THE INTERMOUNTAIN HEART COLLABORATIVE STUDY
    Muhlestein, J. Brent
    May, Heidi
    Winegar, Deborah
    Rollo, Jeffrey
    Connelly, Margery
    Otvos, James
    Anderson, Jeffrey
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2014, 63 (12) : A1389 - A1389
  • [26] BOTH THE NOVEL NMR BIOMARKER OF INFLAMMATION, GLYCA, AND HS-CRP ARE INDEPENDENT AND ADDITIVE PREDICTORS OF FUTURE CARDIOVASCULAR EVENTS AMONG PATIENTS UNDERGOING CORONARY ANGIOGRAPHY: RESULTS FROM THE INTERMOUNTAIN HEART COLLABORATIVE STUDY
    Muhlestein, J. Brent
    May, Heidi
    Galenko, Oxana
    Knowlton, Kirk
    Otvos, James
    Connelly, Margery
    Lappe, Donald
    Anderson, Jeffrey
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2017, 69 (11) : 1069 - 1069
  • [27] Association between the non-high-density lipoprotein cholesterol to high-density lipoprotein cholesterol ratio (NHHR) and cardiovascular outcomes in patients undergoing percutaneous coronary intervention: a retrospective study
    Liu, Jiuling
    Oorloff, Melysze Deanne
    Nadella, Adithya
    Guo, Ping
    Ye, Min
    Wang, Xiaoqing
    Zhao, Hang
    LIPIDS IN HEALTH AND DISEASE, 2024, 23 (01)
  • [28] Pravastatin reduces major coronary events in patients with low levels of both high-density lipoprotein cholesterol and low-density lipoprotein cholesterol: Results from the LIPID study
    Colquhoun, D
    Marschner, I
    Simes, J
    Glasziou, P
    Keech, A
    White, H
    Barter, P
    Tonkin, A
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2001, 37 (02) : 262A - 262A
  • [29] HIGH-DENSITY LIPOPROTEIN (HDL) CHOLESTEROL IS ASSOCIATED WITH RESIDUAL RISK OF CARDIOVASCULAR EVENTS IN PATIENTS WITH STABLE ISCHEMIC HEART DISEASE DESPITE OPTIMAL LEVELS OF LOW-DENSITY LIPOPROTEIN (LDL) CHOLESTEROL: A POST HOC ANALYSIS FROM THE COURAGE TRIAL
    Acharjee, Subroto
    Boden, William E.
    Hartigan, Pamela M.
    Teo, Koon K.
    Maron, David J.
    Sedlis, Steven P.
    Chaitman, Bernard R.
    Spertus, John A.
    Dada, Marcin
    Mancini, G. B. John
    O'Rourke, Robert A.
    Weintraub, William S.
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2011, 57 (14) : E1046 - E1046
  • [30] High levels of high-density lipoprotein cholesterol (HDL-C) and major adverse cardiovascular events and 10-year all-cause mortality:results from Women's Ischemia Syndrome Evaluation (WISE) study
    Ranasinghe, S.
    Cui, Y.
    Obrutu, O.
    Wei, J.
    Gulati, M.
    Bittner, V.
    Reis, S.
    Handberg, E.
    Pepine, C.
    Merz, C. N. Bairey
    EUROPEAN HEART JOURNAL, 2023, 44
12345